VEGFA and neoplasm: This ‘tumour escape’, which is often observed under sustained VEGF/VEGFR inhibition, is likely to be due, at least in part, to compensatory angiogenic signalling, including that mediated by the PDGF/PDGFR and FGF/FGFR pathways [3-12].